Home > Cashflow Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Cashflow Statement

TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax₹1,847 Cr₹1,226 Cr₹1,526 Cr₹1,187 Cr₹562 Cr
Adjustment ₹937 Cr₹1,350 Cr₹993 Cr₹876 Cr₹1,418 Cr
Changes In working Capital ₹-18 Cr₹-352 Cr₹-338 Cr₹-386 Cr₹99 Cr
Cash Flow after changes in Working Capital ₹2,766 Cr₹2,224 Cr₹2,181 Cr₹1,677 Cr₹2,079 Cr
Cash Flow from Operating Activities ₹2,368 Cr₹1,803 Cr₹2,005 Cr₹1,393 Cr₹1,798 Cr
Cash Flow from Investing Activities ₹-2,415 Cr₹-197 Cr₹-449 Cr₹199 Cr₹-241 Cr
Cash Flow from Financing Activities ₹77 Cr₹-1,781 Cr₹-1,651 Cr₹-1,549 Cr₹-1,314 Cr
Net Cash Inflow / Outflow ₹30 Cr₹-175 Cr₹-95 Cr₹42 Cr₹242 Cr
Opening Cash & Cash Equivalents ₹398 Cr₹573 Cr₹662 Cr₹589 Cr₹702 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ₹59 Cr----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹21 Cr₹0.53 Cr₹5.60 Cr₹31 Cr₹-4.33 Cr
Closing Cash & Cash Equivalent ₹509 Cr₹398 Cr₹573 Cr₹662 Cr₹940 Cr

Compare Cashflow Statement of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹86,207.4 Cr 2.9% -2.2% 69% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹364,015.0 Cr 3% 2.3% 68.2% Stock Analytics
CIPLA ₹108,809.0 Cr 2.5% 0.4% 71.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,408.7 Cr -0.2% -4.9% 40.3% Stock Analytics
DIVIS LABORATORIES ₹98,684.0 Cr -1.6% -7% 23.8% Stock Analytics
ZYDUS LIFESCIENCES ₹94,213.7 Cr 5% 10.4% 109.1% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

2.9%

-2.2%

69%

SENSEX

-2.9%

-0.4%

20%


You may also like the below Video Courses